A supported market community: learn, launch, grow, understand tenders and exchange knowledge. Find your place.

Research ethics

Research participation, consent and anonymisation

A practical protocol for collecting useful buyer–supplier learning without treating removal of names as automatic anonymity.

Separate consentRisk-based anonymityCorrection route

One relationship can involve several different permissions

A participant may agree to receive support without agreeing to research. A research participant may agree to aggregated findings but not a named case study. A project may appear in the registry while customer or employee evidence remains confidential.

Market Accord therefore separates service administration, research participation, registry publication, case-study permission, marketing contact and commercial referral.

Publication routes

Choose the least exposing route that remains useful.

The route can change where re-identification or commercial harm becomes more likely.

Named with permission

Organisation and/or individual is named under explicit, informed and revocable permission within agreed limits.

Organisation named, people protected

The organisation is public but individuals, roles or sensitive details are reduced where unnecessary.

Broadly anonymised

Sector, size and geography are generalised; dates and values are banded; rare combinations are removed.

Aggregated cohort

Findings are combined so one participant cannot reasonably be isolated from the published result.

Delayed release

Publication waits until procurement, employment, commercial or personal sensitivity has reduced.

No publication

Evidence informs private improvement only because useful public release cannot be made safe or lawful.

Research record

Every study should be able to answer:

  1. What decision or public question does this research serve?
  2. Who supplied the data and under what relationship?
  3. What was observed, reported, inferred or generated automatically?
  4. What lawful basis and consent routes apply?
  5. Who could be identified or harmed by release?
  6. What transformations reduce re-identification?
  7. What evidence level and limitations should readers see?
  8. Who reviewed the decision and when must it be reconsidered?

Sources and scrutiny

Anonymisation guidance

These sources support the factual context. Market Accord's interpretation is identified separately and should be read with its stated limitations.

  • How do we ensure anonymisation is effective? Information Commissioner's Office · 2025-01-01 · regulatory guidance Open source

Share evidence without surrendering control.

Describe the source and sensitivity first. Market Accord will not request confidential documents through a public form and will agree the route before substantive material is transferred.

Propose evidence